Published in Curr Biol on July 28, 2011
Monoaminergic orchestration of motor programs in a complex C. elegans behavior. PLoS Biol (2013) 1.69
C. elegans outside the Petri dish. Elife (2015) 1.21
The microarchitecture of C. elegans behavior during lethargus: homeostatic bout dynamics, a typical body posture, and regulation by a central neuron. Sleep (2013) 1.11
Modulation of C. elegans touch sensitivity is integrated at multiple levels. J Neurosci (2014) 1.05
A longitudinal study of Caenorhabditis elegans larvae reveals a novel locomotion switch, regulated by G(αs) signaling. Elife (2013) 1.02
An integrated serotonin and octopamine neuronal circuit directs the release of an endocrine signal to control C. elegans body fat. Cell Metab (2013) 1.00
Bending amplitude - a new quantitative assay of C. elegans locomotion: identification of phenotypes for mutants in genes encoding muscle focal adhesion components. Methods (2011) 1.00
Tissue mechanics govern the rapidly adapting and symmetrical response to touch. Proc Natl Acad Sci U S A (2015) 0.83
The neuroethology of C. elegans escape. Curr Opin Neurobiol (2012) 0.83
Mechanosensory molecules and circuits in C. elegans. Pflugers Arch (2014) 0.82
The Natural Biotic Environment of Caenorhabditis elegans. Genetics (2017) 0.77
Evaluation of Head Movement Periodicity and Irregularity during Locomotion of Caenorhabditis elegans. Front Behav Neurosci (2013) 0.75
The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci (1986) 27.07
The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature (1991) 5.30
Developmental genetics of the mechanosensory neurons of Caenorhabditis elegans. Dev Biol (1981) 4.93
The MEC-4 DEG/ENaC channel of Caenorhabditis elegans touch receptor neurons transduces mechanical signals. Nat Neurosci (2004) 4.52
OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans. J Neurosci (1997) 4.06
A dual mechanosensory and chemosensory neuron in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1993) 3.15
The natural history of Caenorhabditis elegans. Curr Biol (2010) 2.75
Tyramine Functions independently of octopamine in the Caenorhabditis elegans nervous system. Neuron (2005) 2.54
Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2003) 2.50
A tyramine-gated chloride channel coordinates distinct motor programs of a Caenorhabditis elegans escape response. Neuron (2009) 2.01
Making an escape: development and function of the Drosophila giant fibre system. Semin Cell Dev Biol (2005) 1.77
Mutations in the Caenorhabditis elegans unc-4 gene alter the synaptic input to ventral cord motor neurons. Nature (1992) 1.37
Ligand-gated chloride channels are receptors for biogenic amines in C. elegans. Science (2009) 1.30
Fungal Morphogenesis: Ring Formation and Closure by Arthrobotrys dactyloides. Science (1967) 1.27
Carnivorous fungi from Cretaceous amber. Science (2007) 1.26
Carnivorous mushrooms. Science (1984) 1.19
Phylogenetics and evolution of nematode-trapping fungi (Orbiliales) estimated from nuclear and protein coding genes. Mycologia (2006) 1.17
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol (2009) 14.42
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov (2007) 4.03
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology (2012) 3.58
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic Wnt signaling. Cell (2012) 3.50
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol (2005) 3.09
A multiparameter network reveals extensive divergence between C. elegans bHLH transcription factors. Cell (2009) 3.02
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol (2008) 2.96
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain (2007) 2.96
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81
Optogenetic manipulation of neural activity in freely moving Caenorhabditis elegans. Nat Methods (2011) 2.80
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol (2007) 2.72
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68
Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol (2002) 2.58
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol (2008) 2.41
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology (2012) 2.26
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch Neurol (2008) 2.25
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol (2010) 2.20
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Diagnostic evaluation of elderly patients with mild memory problems. Ann Intern Med (2003) 2.15
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment. Acta Neuropathol (2010) 2.12
A tyramine-gated chloride channel coordinates distinct motor programs of a Caenorhabditis elegans escape response. Neuron (2009) 2.01
Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimers Dement (2008) 1.90
Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord (2005) 1.82
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement (2013) 1.77
Monoaminergic orchestration of motor programs in a complex C. elegans behavior. PLoS Biol (2013) 1.69
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol (2007) 1.60
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry (2010) 1.59
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol (2007) 1.57
TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol (2007) 1.57
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging (2012) 1.49
Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch Neurol (2007) 1.45
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43
Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol (2010) 1.39
Autoregulatory and paracrine control of synaptic and behavioral plasticity by octopaminergic signaling. Nat Neurosci (2010) 1.38
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol (2010) 1.38
Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons. J Biol Chem (2012) 1.32
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One (2011) 1.32
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol (2012) 1.32
Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope. Cell Rep (2013) 1.31
Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol (2011) 1.26
Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment. Ann Neurol (2005) 1.23
Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. J Nucl Med (2006) 1.22
Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain (2011) 1.22
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Stat Med (2004) 1.18
T1rho MRI of Alzheimer's disease. Neuroimage (2008) 1.13
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. J Neurol Neurosurg Psychiatry (2012) 1.12
Intercellular calcium signaling in a gap junction-coupled cell network establishes asymmetric neuronal fates in C. elegans. Development (2012) 1.10
Visual perceptual functions predict instrumental activities of daily living in patients with dementia. Neuropsychiatry Neuropsychol Behav Neurol (2002) 1.10
Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale. Alzheimer Dis Assoc Disord (2009) 1.09
Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord (2012) 1.08
Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center. Am J Geriatr Psychiatry (2011) 1.06
Incorporating clonal growth form clarifies the role of plant height in response to nitrogen addition. Oecologia (2012) 1.05
Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease. Alzheimers Dement (2009) 1.05
Rank clocks and plant community dynamics. Ecology (2008) 1.03
ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord (2006) 1.01
Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease. J Alzheimers Dis (2012) 1.01
Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol (2003) 1.00
Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators. IRB (2003) 0.98
Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques. Infect Immun (2005) 0.97
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol (2010) 0.97
T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia. J Neurol (2010) 0.97
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. J Neuropathol Exp Neurol (2014) 0.94
Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Mol Cell Proteomics (2011) 0.92
Memory encoding and retrieval in frontotemporal dementia and Alzheimer's disease. Neuropsychology (2002) 0.91
Monoclonal antibodies against Enterocytozoon bieneusi of human origin. Clin Diagn Lab Immunol (2005) 0.90
Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Dis Assoc Disord (2009) 0.89
Early marker for Alzheimer's disease: hippocampus T1rho (T(1rho)) estimation. J Magn Reson Imaging (2009) 0.88
Amyloid imaging and cognitive decline in nondemented oldest-old: the 90+ Study. Alzheimers Dement (2012) 0.88
Emotion-discrimination deficits in mild Alzheimer disease. Am J Geriatr Psychiatry (2005) 0.88
Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials. Alzheimer Dis Assoc Disord (2006) 0.88
The NCA sodium leak channel is required for persistent motor circuit activity that sustains locomotion. Nat Commun (2015) 0.87
Biofuels: network analysis of the literature reveals key environmental and economic unknowns. Environ Sci Technol (2012) 0.86
A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1. J Infect Dis (2010) 0.86
Relationship between Alzheimer's disease severity and patient participation in decisions about their medical care. J Geriatr Psychiatry Neurol (2002) 0.85
Validation of consensus panel diagnosis in dementia. Arch Neurol (2010) 0.85
Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis (2003) 0.84
T(1ρ) MRI in Alzheimer's disease: detection of pathological changes in medial temporal lobe. J Neuroimaging (2011) 0.84
Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS (2012) 0.84
Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.84
Failure to propagate Cryptosporidium spp. in cell-free culture. J Parasitol (2006) 0.84
Disturbed visual processing contributes to impaired reading in Alzheimer's disease. Neuropsychologia (2002) 0.83
The neuroethology of C. elegans escape. Curr Opin Neurobiol (2012) 0.83
Comparative multiresolution wavelet analysis of ERP spectral bands using an ensemble of classifiers approach for early diagnosis of Alzheimer's disease. Comput Biol Med (2006) 0.83
Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology. Alzheimers Dement (2012) 0.82
Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum. Arch Neurol (2006) 0.82
F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients. Cogn Behav Neurol (2008) 0.81
Visual processing impairments and decrements in regional brain activity in Alzheimer's disease. J Clin Exp Neuropsychol (2004) 0.80
Identification of distinct tyraminergic and octopaminergic neurons innervating the central complex of the desert locust, Schistocerca gregaria. J Comp Neurol (2013) 0.80
Why would caregivers not want to treat their relative's Alzheimer's disease? J Am Geriatr Soc (2003) 0.80
ERP based decision fusion for AD diagnosis across cohorts. Conf Proc IEEE Eng Med Biol Soc (2009) 0.79
Memory distortion in Alzheimer's disease: deficient monitoring of short- and long-term memory. Neuropsychology (2012) 0.78
Failure of biomarkers in clinical trials of Alzheimer's disease: blaming the messenger? J Alzheimers Dis (2009) 0.75
The Dementia Severity Rating Scale predicts clinical dementia rating sum of boxes scores. Alzheimer Dis Assoc Disord (2015) 0.75